These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 15629591

  • 1. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Allen Z, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):32-43. PubMed ID: 15629591
    [Abstract] [Full Text] [Related]

  • 2. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.
    Urology; 2005 Jan 01; 65(1):95-100. PubMed ID: 15667872
    [Abstract] [Full Text] [Related]

  • 3. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    Urology; 2004 Oct 01; 64(4):754-9. PubMed ID: 15491715
    [Abstract] [Full Text] [Related]

  • 4. Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1056-62. PubMed ID: 15001245
    [Abstract] [Full Text] [Related]

  • 5. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Adamovich E.
    W V Med J; 2005 Mar 15; 101(4):168-71. PubMed ID: 16296198
    [Abstract] [Full Text] [Related]

  • 6. Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):669-77. PubMed ID: 16682149
    [Abstract] [Full Text] [Related]

  • 7. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ, Brandt D, Schour L, Hill DR.
    Am J Clin Oncol; 2009 Aug 01; 32(4):342-7. PubMed ID: 19398902
    [Abstract] [Full Text] [Related]

  • 8. Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E, Lief J.
    Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):34-40. PubMed ID: 17289288
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E.
    Urology; 2005 Nov 01; 66(5):1048-53. PubMed ID: 16286122
    [Abstract] [Full Text] [Related]

  • 10. Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer.
    Merrick GS, Wallner KE, Butler WM, Galbreath RW, Allen ZA, Adamovich E, True L.
    BJU Int; 2006 Aug 01; 98(2):324-8. PubMed ID: 16879672
    [Abstract] [Full Text] [Related]

  • 11. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW, Schild SE, Vora SA, Halyard MY.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):24-9. PubMed ID: 15337536
    [Abstract] [Full Text] [Related]

  • 12. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
    Potters L, Cha C, Oshinsky G, Venkatraman E, Zelefsky M, Leibel S.
    Cancer J Sci Am; 1999 Sep 01; 5(5):301-6. PubMed ID: 10526671
    [Abstract] [Full Text] [Related]

  • 13. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A, Merrick GS, Butler WM, Wallner KE, Allen ZA, Galbreath RW, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):136-43. PubMed ID: 16198062
    [Abstract] [Full Text] [Related]

  • 14. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.
    Moyad MA, Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, Adamovich E.
    Urology; 2005 Dec 01; 66(6):1150-4. PubMed ID: 16360430
    [Abstract] [Full Text] [Related]

  • 15. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Dec 01; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 16. 20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trial.
    Merrick GS, Wallner KE, Butler WM, Galbreath RW, Taira AV, Orio P, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):e449-55. PubMed ID: 22196131
    [Abstract] [Full Text] [Related]

  • 17. Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?
    Bittner N, Merrick GS, Wallner KE, Butler WM, Galbreath R, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1078-84. PubMed ID: 19553031
    [Abstract] [Full Text] [Related]

  • 18. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):664-73. PubMed ID: 11849788
    [Abstract] [Full Text] [Related]

  • 19. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience.
    Sylvester JE, Grimm PD, Blasko JC, Millar J, Orio PF, Skoglund S, Galbreath RW, Merrick G.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):57-64. PubMed ID: 17084544
    [Abstract] [Full Text] [Related]

  • 20. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P, Kuban D, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):415-9. PubMed ID: 15667961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.